Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Roles of transposable elements in the regulation of mammalian transcription
Raquel Fueyo, Julius Judd, Cédric Feschotte, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 7, pp. 481-497
Open Access | Times Cited: 247
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants
James W. Saville, Dhiraj Mannar, Xing Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison J. Greaney, Tyler N. Starr, Rachel Eguia, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010248-e1010248
Open Access | Times Cited: 67
#COVIDisAirborne: AI-enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol
Abigail C. Dommer, Lorenzo Casalino, Fiona L. Kearns, et al.
The International Journal of High Performance Computing Applications (2022) Vol. 37, Iss. 1, pp. 28-44
Open Access | Times Cited: 59
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
A comparative overview of SARS‑CoV‑2 and its variants of concern
Aqeel Ahmad, Mirna Fawaz, Arafeen Aisha
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 37
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, Christian Saliba, John E. Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 53
Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion
Li Shen, Timothy J. Triche, Jennifer Dien Bard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 51
The way of SARS-CoV-2 vaccine development: success and challenges
Yetian Dong, Tong Dai, Bin Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 50
SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10836-10836
Open Access | Times Cited: 40
Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike
Diego Cantoni, Matthew J Murray, Mphatso D. Kalemera, et al.
EMBO Reports (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 32
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2485-2485
Open Access | Times Cited: 32
Structure-activity relationships of B.1.617 and other SARS-CoV-2 spike variants
Tzu‐Jing Yang, Pei‐Yu Yu, Yuan‐Chih Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 31
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
SARS-CoV-2 spike conformation determines plasma neutralizing activity
John E. Bowen, Alexandra C. Walls, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
#COVIDisAirborne: AI-Enabled Multiscale Computational Microscopy of Delta SARS-CoV-2 in a Respiratory Aerosol
Abigail C. Dommer, Lorenzo Casalino, Fiona L. Kearns, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 23
Association of disease severity and death outcome with vaccination status of admitted COVID-19 patients in delta period of SARS-COV-2 in mixed variety of vaccine background
Javaria Aslam, Muhammad Rauf ul Hassan, Qindeel Fatima, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 7, pp. 103329-103329
Open Access | Times Cited: 16
Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2
Yu Shi, Xu Zheng, Yanqiu Zhou, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011789-e1011789
Open Access | Times Cited: 9
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Baoling Ying, Bradley Whitener, Laura A. VanBlargan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Is Omicron the last SARS-CoV-2 Variant of Concern?
Farid Rahimi, Amin Talebi Bezmin Abadi
Archives of Medical Research (2022) Vol. 53, Iss. 3, pp. 336-338
Open Access | Times Cited: 15
Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Anett Hudák, Gábor Veres, Annamária Letoha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 796-796
Open Access | Times Cited: 14
A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
Xiaomin Duan, Rui Shi, Pulan Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top